Skip to main content

Table 1 The clinical manifestation and biochemical characterization of GD, HT and AITD

From: Association of single nucleotide polymorphism rs3792876 in SLC22A4 gene with autoimmune thyroid disease in a Chinese Han population

  GD pedigree HT pedigree AITD pedigrees
  GD patients Controls HT patients Controls AITD patients Controls
Gender (M/F) 45/156 (1:3.47) 136/141 (1:1.04) 8/21 (1/2.62) 18/28 (1:1.56) 54/176 (1:3.25) 153/170 (1:1.11)
Age (year) 43.72 ± 14.31 48.95 ± 16.98 42.45 ± 19.85 47.55 ± 16.75 43.60 ± 15.17 48.40 ± 17.21
TSH (mIU/L) 0.10 (0.06-1.83) 1.26 (0.79-2.06) 2.04 (0.23-9.06) 2.45 (1.45-3.33) 0.23 (0.01-2.32) 1.37 (0.83-2.30)
FT4 (pmol/L) 25.81 ± 18.55 16.64 ± 3.07 18.79 ± 9.87 16.50 ± 2.01 24.91 ± 17.82 16.62 ± 2.94
FT3 (pmol/L) 7.58 ± 6.72 4.17 ± 0.89 4.71 ± 1.89 4.38 ± 0.97 7.21 ± 6.39 4.20 ± 0.90
TPOAb (IU/ml) 368.50 (46.85-1000) 10.10 (10.00-29.20) 1000.00 (458.75-1000.00) 10.60 (10.00-158.50) 503.50 (53.13-1000.00) 10.10 (10.00-33.35)
TgAb (IU/ml) 59.95 (20.00-460.00) 20.00 (20.00-94.70) 80.60 (31.18-3000.00) 20.00 (20.00-45.70) 59.95 (20.00-519.50) 20.00 (20.00-20.00)